셀트리온헬스케어
'파마포럼'
https://pharmaphorum.com/news/celltrion-closes-in-on-covid-19-antibody-market-after-trial-success/
'크리니컬트라이얼'
https://www.clinicaltrialsarena.com/news/celltrion-drug-therapeutic-efficacy/
'afp 통신'
https://www.afp.com/fr/infos/1309/celltrion-annonce-des-resultats-positifs-defficacite-et-de-tolerance-de-lessai-clinique-mondial-de-phase-ii/iii-du-candidat-medicament-ct-p59-regdanvimab-contre-la-covid-19-202101140060771
'바이오스페이스'
https://www.biospace.com/article/clinical-catch-up-january-11-15
'파마샷'
https://pharmashots.com/press-releases/celltrion-group-announces-positive-top-line-efficacy-and-safety-data-from-global-phase-ii-iii-clinical-trial-of-covid-19-treatment-candidate-ct-p59/
전문가방송
연관검색종목 05.02 06:30 기준
0/1000 byte